Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk for Proliferative Vitreoretinopathy (PVR)”

2 trials

Showing 2 of 2 results

Large-scale testing (Phase 3)Study completedNCT02834559
What this trial is testing

Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.

Who this might be right for
Rhegmatogenous Retinal DetachmentHigh-risk for Proliferative Vitreoretinopathy (PVR)
Universitätsklinikum Köln 326
Large-scale testing (Phase 3)Active Not RecruitingNCT05660447
What this trial is testing

A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR

Who this might be right for
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Wills Eye 80

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation